PT - JOURNAL ARTICLE AU - Robert M. Moldwin AU - Vishaan Nursey AU - Oksana Yaskiv AU - Siddhartha Dalvi AU - Michael Funaro AU - William DeGouveia AU - Marina Ruzimovsky AU - Horacio R. Rilo AU - Edmund J. Miller AU - Souhel Najjar AU - Inna Tabansky AU - Joel N.H. Stern TI - Immune Cell Profiles and Cytokine Levels of Patients with Interstitial Cystitis/Bladder Pain Syndrome AID - 10.1101/2020.12.17.20248414 DP - 2020 Jan 01 TA - medRxiv PG - 2020.12.17.20248414 4099 - http://medrxiv.org/content/early/2020/12/19/2020.12.17.20248414.short 4100 - http://medrxiv.org/content/early/2020/12/19/2020.12.17.20248414.full AB - Aims To quantify the number of immune cells in the bladder urothelium and concentrations of urinary cytokines in patients with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS). To identify differences in these measures in IC/BPS patients with Hunner’s lesions (IC/BPS-HL) and without Hunner’s lesions (IC/BPS-NHL).Methods Bladder tissue biopsies were obtained from 48 patients with IC/BPS-HL and unaffected controls (UC) and stained with antibodies for various immune cell markers such as CD138, CD20 and CD56. Levels of cytokines (Interferon (IFN)-γ, Interleukin (IL)-1β, IL-2, IL- 4, IL-6, IL-8, IL12P70, IL-13, and TNF-α) were measured from normalized urine obtained from 18 IC/BPS-HL, 18 IC/BPS-NHL, and 4 UC.Results Numbers of CD138+ plasma cells, CD20+ B cells, and CD3+ T cells were significantly increased (50 fold, 30 fold, and an almost 3 fold increase, respectively; p-values: 1.34E-06, 3.26E-04, and 2.52E-6) in the bladders of IC/BPS-HL patients compared to UC. Patients with IC/BPS-HL had significantly elevated urinary levels of IL-6 (p=0.0028) and TNF-α (p=0.009) compared to patients with IC/BPS-NHL and UC. In contrast, IL-12p70 levels were significantly higher in the patients with IC/BPS-NHL than in HL patients (p=0.033). No significant difference in IL-12p70 levels were observed between IC/BPS-HL and UC.Conclusion Different cytokines were elevated in the urine of IC/BPS patients with and without HL, suggesting differences in underlying disease processes. Elevated levels of CD138+, CD20+, and CD3+ cells in HL indicate B and T-cell involvement in lesion formation. Determining which cytokines and immunological pathways are present in IC/BPS-HL could elucidate the disease mechanism.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project was supported by grants received from the Kavli Foundation and H.F. Langbert Neuroimmunology Research Fund.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All research protocols and study related documents were assessed and approved by the Institutional Review Board at Northwell Health (Study number 17-0254 NSUH).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAs per IRB guidelines, all clinical data pertaining to this study are stored within secure Northwell Health cloud based storage systems and all hard copy documentation is stored within access controlled Northwell Health facilities. Data can be made available upon request.